Tommie Reerink

Tommie Reerink is a Biotechnology Equity Research Associate at Goldman Sachs, with a focus on the US Biotechnology sector since July 2021. Responsibilities include client communication, publishing ratings changes, earnings reports, and writing industry analysis. Previously, Tommie served as a Biotechnology Equity Research Analyst, co-authoring significant reports on artificial intelligence in drug discovery and evaluating biotech valuations. Tommie's experience also includes facilitating math classes for first-year students at the Massachusetts Institute of Technology (MIT) and a summer internship as a Biopharma Equity Analyst at Goldman Sachs. Tommie, a graduate of MIT with a Bachelor of Science in Mathematics and a Bachelor's degree in Music, has engaged in research funded by the National Science Foundation and the National Security Agency, presenting findings at key mathematics conferences.